Literature DB >> 10931460

Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.

H Moch1, T Gasser, M B Amin, J Torhorst, G Sauter, M J Mihatsch.   

Abstract

BACKGROUND: A new, internationally accepted histologic classification of renal cell carcinoma (RCC) and a new edition of the TNM staging system were introduced in 1997. In the latter, there was a dramatic change in the pT classification of organ-confined renal cancer in which the break point between category pT1 and pT2 was increased from 2.5 cm to 7 cm.
METHODS: To study the significance of the new pT classification and the new recommendations for histologic classification, 588 nephrectomy specimens were reevaluated to define morphologic prognostic parameters in RCC. pT classification (TNM 1997), histologic subtype, histologic tumor grade, presence of necrosis, and sarcomatoid differentiation were assessed.
RESULTS: The histopathologic review according to the new classification revealed 487 conventional (clear cell) (83%), 64 papillary (11%), 31 chromophobe (5%), and 6 collecting duct (1%) RCCs. Clinical follow-up was available for 470 RCCs. The new pT classification (1997) was strongly correlated with patient survival (P < 0.0001). Histologic grade, presence of necrosis, and sarcomatoid differentiation provided independent prognostic information on the clear cell subtype of renal cancer. Sarcomatoid differentiation, but not tumor necrosis, portended a dismal prognosis for patients with papillary RCC. Chromophobe RCC was associated with a significantly better prognosis than clear cell RCC (P = 0.05). Papillary RCC with scanty cytoplasm and small cells (type 1) behaved less aggressively than papillary tumors with eosinophilic cytoplasm and large cells (type 2; P < 0.001).
CONCLUSIONS: Accurate histologic classification according to the new recommendations has implications because the prognostic importance of other histologic features that are of independent significance varies with tumor subtype. The data suggest that the new pT classification allows good separation of prognostic groups of patients with renal cancer. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 10931460

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  87 in total

1.  Pathological implications of areas of lower enhancement on contrast-enhanced computed tomography in renal-cell carcinoma: additional information for selecting candidates for surveillance protocols.

Authors:  Miguel Villalobos-Gollás; Bernardo Aguilar-Davidov; Carolina Culebro-García; Martha O Gómez-Alvarado; Priscila Rojas-Garcia; Raúl Ibarra-Fombona; Norma Uribe-Uribe; Guillermo Feria-Bernal; Ricardo Castillejos-Molina; Mariano Sotomayor; Fernando Gabilondo; Francisco Rodríguez-Covarrubias
Journal:  Int Urol Nephrol       Date:  2012-05-22       Impact factor: 2.370

Review 2.  Chinese guidelines on the management of renal cell carcinoma (2015 edition).

Authors:  Jun Guo; Jianhui Ma; Yan Sun; Shukui Qin; Dingwei Ye; Fangjian Zhou; Zhisong He; Xinan Sheng; Feng Bi; Dengfeng Cao; Yingxia Chen; Yiran Huang; Houjie Liang; Jun Liang; Jiwei Liu; Wenchao Liu; Yueyin Pan; Yongqian Shu; Xin Song; Weibo Wang; Xiuwen Wang; Xiaoan Wu; Xiaodong Xie; Xin Yao; Shiying Yu; Yanqiao Zhang; Aiping Zhou
Journal:  Ann Transl Med       Date:  2015-11

3.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

4.  Histologic coagulative tumour necrosis as a prognostic indicator of aggressiveness in renal, lung, thyroid and colorectal carcinomas: A brief review.

Authors:  Rosario Caruso; Antonino Parisi; Anna Bonanno; Domenica Paparo; Emilia Quattrocchi; Giovanni Branca; Marco Scardigno; Francesco Fedele
Journal:  Oncol Lett       Date:  2011-09-16       Impact factor: 2.967

5.  [The WHO/ISUP grading system for renal carcinoma].

Authors:  H Moch
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

6.  Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma.

Authors:  Carl Ludwig Behnes; Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Philipp Ströbel; Heinz-Joachim Radzun
Journal:  Virchows Arch       Date:  2013-12-11       Impact factor: 4.064

7.  PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception?

Authors:  Franziska Erlmeier; Arndt Hartmann; Michael Autenrieth; Max Wiedemann; Philipp Ivanyi; Sandra Steffens; Wilko Weichert
Journal:  Med Oncol       Date:  2016-09-30       Impact factor: 3.064

8.  Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness.

Authors:  Giueng-Chueng Wang; Po-Shiuan Hsieh; Hsian-He Hsu; Guang-Huan Sun; Shin Nieh; Cheng-Ping Yu; Jong-Shiaw Jin
Journal:  World J Urol       Date:  2009-02-15       Impact factor: 4.226

9.  Severe blood loss anaemia and recurrent intussusceptions as first presentation of bowel metastatic renal cell carcinoma: A case report and review of the literature.

Authors:  Claudia Trojaniello; Maria Giuseppa Vitale; Biagio Trojaniello; Maria Luisa Lentini Graziano; Mariarosa Coccaro; Giacomo Cartenì; Vincenzo Montesarchio
Journal:  Mol Clin Oncol       Date:  2017-08-07

10.  Sub-typing of renal cell tumours; contribution of ancillary techniques.

Authors:  Dinesh Pradhan; Nandita Kakkar; Amanjit Bal; Shrawan Kumar Singh; Kusum Joshi
Journal:  Diagn Pathol       Date:  2009-06-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.